If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Free Content Pharmacological Interventions to Decompression Sickness in Rats: Comparison of Five Agents

(HTML 79.5kb)
(PDF 504.8kb)
Download Article:


Montcalm-Smith EA, Fahlman A, Kayar SR. Pharmacological interventions to decompression sickness in rats: comparison of five agents. Aviat Space Environ Med 2008; 79:7–13.

Introduction: This research investigated whether decompression sickness (DCS) risk or severity could be reduced using drug interventions that are easier to implement and equal to or more efficacious than recompression therapy. Methods: Using a rat model of DCS, anti-inflammatory or anticoagulant drugs, including lidocaine, aspirin (ASA), methylprednisolone (MP), alpha-phenyl-N-butylnitrone (PBN), and transsodium crocetinate (TSC) were tested to determine their effect on incidence of DCS, death, and time of symptom onset. Each treatment group consisted of ∼40 animals that received the drug and ∼40 controls. Animals were exposed to one of five compression and decompression profiles with pressure ranging from 6.3 ATA (175 fsw) to 8.0 ATA (231 fsw); bottom time was either 60 or 90 min; and decompression rate was either 1.8 or 15 ATA ยท min−1. Following decompression, the rats were observed for 30 min while walking on a wheel. DCS was defined as an ambulatory deficit or abnormal breathing. Results: None of the drugs reached statistical significance for all DCS manifestations. Lidocaine post-dive and MP were the only treatments with marginally (P < 0.15) significant differences in DCS outcomes compared to controls. Lidocaine post-dive significantly decreased the incidence of neurological DCS from 73–51%. MP significantly extended the time of onset of death from DCS from 5.4 min to 7.1 min. Discussion: Of the treatments investigated, lidocaine given post-dive has the best chance of success in adjuvant therapy of DCS. Future studies might investigate adjuvant drugs given in combination or during recompression.

Keywords: DCS; adjunctive therapy; alpha-phenyl-N-butylnitorne; aspirin; lidocaine; methylprednisolone; transsodium crocetinate

Document Type: Research Article

DOI: http://dx.doi.org/10.3357/ASEM.2071.2008

Affiliations: From the Naval Medical Research Center, Silver Spring, MD (E. A. Montcalm-Smith, S. R. Kayar), and the UBC Marine Mammal Research Unit, The University of British Columbia, Vancouver, BC, Canada (A. Fahlman).

Publication date: January 1, 2008

More about this publication?
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more